117 related articles for article (PubMed ID: 33758617)
1. SCARA5 inhibits gastric cancer progression via epithelial-mesenchymal transition suppression.
Zhang H; Liu C; Wang X; Wang Y; Zheng J
J Cancer; 2021; 12(8):2412-2421. PubMed ID: 33758617
[TBL] [Abstract][Full Text] [Related]
2. Scavenger receptor class A, member 5 is associated with thyroid cancer cell lines progression via epithelial-mesenchymal transition.
Zheng C; Xia EJ; Quan RD; Bhandari A; Wang OC; Hao RT
Cell Biochem Funct; 2020 Mar; 38(2):158-166. PubMed ID: 31989658
[TBL] [Abstract][Full Text] [Related]
3. Suppression of SCARA5 by Snail1 is essential for EMT-associated cell migration of A549 cells.
Liu J; Hu G; Chen D; Gong AY; Soori GS; Dobleman TJ; Chen XM
Oncogenesis; 2013 Sep; 2(9):e73. PubMed ID: 24061576
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of SCARA5 inhibits tumor proliferation and invasion in osteosarcoma via suppression of the FAK signaling pathway.
Wen X; Wang N; Zhang F; Dong C
Mol Med Rep; 2016 Mar; 13(3):2885-91. PubMed ID: 26847210
[TBL] [Abstract][Full Text] [Related]
5. SCARA5 plays a critical role in the progression and metastasis of breast cancer by inactivating the ERK1/2, STAT3, and AKT signaling pathways.
You K; Su F; Liu L; Lv X; Zhang J; Zhang Y; Liu B
Mol Cell Biochem; 2017 Nov; 435(1-2):47-58. PubMed ID: 28497372
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic upregulation of Class A scavenger receptor member 5 inhibits tumor growth and metastasis.
Yan N; Zhang S; Yang Y; Cheng L; Li C; Dai L; Dai L; Zhang X; Fan P; Tian H; Wang R; Chen X; Su X; Li Y; Zhang J; Du T; Wei Y; Deng H
Cancer Sci; 2012 Sep; 103(9):1631-9. PubMed ID: 22642751
[TBL] [Abstract][Full Text] [Related]
7. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway.
Chen DD; Cheng JT; Chandoo A; Sun XW; Zhang L; Lu MD; Sun WJ; Huang YP
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G147-G160. PubMed ID: 30943047
[TBL] [Abstract][Full Text] [Related]
8. microRNA-665 is down-regulated in gastric cancer and inhibits proliferation, invasion, and EMT by targeting PPP2R2A.
Zhang M; Wang S; Yi A; Qiao Y
Cell Biochem Funct; 2020 Jun; 38(4):409-418. PubMed ID: 31923339
[TBL] [Abstract][Full Text] [Related]
9. Wnt7a, frequently silenced by CpG methylation, inhibits tumor growth and metastasis via suppressing epithelial-mesenchymal transition in gastric cancer.
Liu Y; Qiao Y; Zhang H; Li W; Zheng J
J Cell Biochem; 2019 Oct; 120(10):18142-18151. PubMed ID: 31144375
[TBL] [Abstract][Full Text] [Related]
10. Metastasis suppressor protein 1 regulated by PTEN suppresses invasion, migration, and EMT of gastric carcinoma by inactivating PI3K/AKT signaling.
Wang H; Zhao Y; Cao L; Zhang J; Wang Y; Xu M
J Cell Biochem; 2019 Mar; 120(3):3447-3454. PubMed ID: 30246429
[TBL] [Abstract][Full Text] [Related]
11. Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition.
Li LQ; Pan D; Chen Q; Zhang SW; Xie DY; Zheng XL; Chen H
Cell Physiol Biochem; 2018; 47(4):1533-1545. PubMed ID: 29940566
[TBL] [Abstract][Full Text] [Related]
12. The Novel Methylation Biomarker SCARA5 Sensitizes Cancer Cells to DNA Damage Chemotherapy Drugs in NSCLC.
Peng Q; Liu Y; Kong X; Xian J; Ye L; Yang L; Guo S; Zhang Y; Zhou L; Xiang T
Front Oncol; 2021; 11():666589. PubMed ID: 34150631
[TBL] [Abstract][Full Text] [Related]
13. CSN5 Promotes Hepatocellular Carcinoma Progression by SCARA5 Inhibition Through Suppressing β-Catenin Ubiquitination.
Liu H; Hu J; Pan H; Luo D; Huang M; Xu W
Dig Dis Sci; 2018 Jan; 63(1):155-165. PubMed ID: 29189991
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA CCDC66 promotes gastric cancer progression by regulating c-Myc and TGF-β signaling pathways.
Xu G; Chen Y; Fu M; Zang X; Cang M; Niu Y; Zhang W; Zhang Y; Mao Z; Shao M; Qian H; Xu W; Cai H; Jiang P; Zhang X
J Cancer; 2020; 11(10):2759-2768. PubMed ID: 32226494
[No Abstract] [Full Text] [Related]
15. Knockdown of SCARA5 inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration through suppression of the PDGF signaling pathway.
Zhao J; Jian L; Zhang L; Ding T; Li X; Cheng D; Niu S; Sun L; Li E; Liu S; Jiang Y; Liu L
Mol Med Rep; 2016 May; 13(5):4455-60. PubMed ID: 27035566
[TBL] [Abstract][Full Text] [Related]
16. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling.
Jiang L; Liu JY; Shi Y; Tang B; He T; Liu JJ; Fan JY; Wu B; Xu XH; Zhao YL; Qian F; Cui YH; Yu PW
J Exp Clin Cancer Res; 2019 May; 38(1):206. PubMed ID: 31113461
[TBL] [Abstract][Full Text] [Related]
17. The SOX2OT/miR-194-5p axis regulates cell proliferation and mobility of gastric cancer through suppressing epithelial-mesenchymal transition.
Wei R; Ding C; Rodrìguez RA; Del Mar Requena Mullor M
Oncol Lett; 2018 Nov; 16(5):6361-6368. PubMed ID: 30405772
[TBL] [Abstract][Full Text] [Related]
18. LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway.
Yang XZ; Cheng TT; He QJ; Lei ZY; Chi J; Tang Z; Liao QX; Zhang H; Zeng LS; Cui SZ
Mol Cancer; 2018 Aug; 17(1):126. PubMed ID: 30134915
[TBL] [Abstract][Full Text] [Related]
19. Identification of
Wang F; Cao X; Yin L; Wang Q; He Z
DNA Cell Biol; 2020 Oct; 39(10):1813-1824. PubMed ID: 32816580
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA AFAP1-antisense RNA 1 promotes the proliferation, migration and invasion of gastric cancer cells and is associated with poor patient survival.
Zhao H; Zhang K; Wang T; Cui J; Xi H; Wang Y; Song Y; Zhao X; Wei B; Chen L
Oncol Lett; 2018 Jun; 15(6):8620-8626. PubMed ID: 29805596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
